GO TO PAGE. Thank you, and welcome all to the audio webcast of Galapagos' H1 2021 results. Galapagos NV (GLPG) CEO Paul Stoffels on Q1 2022 Results - Earnings Call Transcript Galapagos NV (NASDAQ:NASDAQ:GLPG) Q1 2022 Results Conference Call May 6, 2022 08:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief... May 6, 2022. seekingalpha.com . Galapagos NV (GLPG) Q4 2021 Earnings Conference Call February 25, 2022 8:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Onno van de Stolpe - Chief Executive Officer Bart Filius - Chief Operating Officer Walid Abi-Saab - Chief Medical … Thank you and welcome all to the audio webcast of Galapagos' full year 2020 results. Thank you operator and welcome all to the audio webcast of Galapagos Q3 2021 results. Skip to main navigation SEC Filings SEC Filing Keyword Search. Governance. Long-Term Strategic Plan . VP Investor Relations. Mechelen, Belgium; 1 June 2022, 22.01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received a transparency notification from FMR LLC. Royal Bank of Canada lifted their price objective on [] Galapagos NV specializes in the research and development of drugs based on novel targets discovered and validated in human primary cells. This can mainly be explained by currency exchange losses on U.S. dollar in 2019, as compared to non-cash currency exchange gains on U.S. dollar in 2018. Vice President Investor Relations Galapagos NV Generaal De Wittelaan L11 A3 2800 Mechelen, Belgium Tel +1 781 460 1784 Email: ir@glpg.com. Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage biotechnology company specialized in the discovery and development of small molecule medicines with novel modes of action. Our corporate governance processes are directed to ensure uncompromised business ethics, robust and transparent corporate supervision, risk management and regular dialogue with shareholders. Send e-mail. Investor Relations Besi. Die Umsatzerlöse verteilen sich geografisch wie folgt: Europa (1,2 %) und Nordamerika (98,8 %). CTP is an incredible business and success story which we are proud of and passionate about. Company. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis and other indications. Galapagos NV (GLPG) CEO Paul Stoffels on Q1 2022 Results - Earnings Call Transcript Galapagos NV (NASDAQ:NASDAQ:GLPG) Q1 2022 Results Conference Call May 6, 2022 08:00 AM ET Company Participants Sofie Van Gijsel - Senior Director, Investor Relations Paul Stoffels - Chief... May 6, 2022. seekingalpha.com . Information for Shareholders and Investors. Galapagos NV. The burden of inflammatory bowel disease in Europe. Investors | Corporate. Vice President, Investor Relations at Galapagos NV. Management, Profil, Aktionärsstruktur und Bilanzdaten. Investor Relations USA. We look forward to host you on June 13th. For any other matters not directly related to Investor Relations, please visit our company contacts page. compatibility mode windows 10 not available. Investors | Corporate. Sofie Van Gijsel Senior Director Investor Relations +1 781 296 1143. It was the year that saw the commercial side of our business step into the spotlight. Sofie Van Gijsel-- Director Investor Relations. Yahoo. Galapagos NV forms part of the Bel20 index (top 20 listed companies) on Euronext Brussels, the AEX Index (top 25 listed companies) on Euronext Amsterdam, and the Nasdaq … €. +1 781 460 1784.
Taylor Lorenz Missouri Accident,
Guerlain Après L Ondee Sample,
Bootsfahrschule Hoffmann,
Evangelisches Gesangbuch Württemberg Digital,
Articles G
